UNSPSC 51287003: Chaulmosulfone

This classification denotes a topical anti-infective agent with the molecular formula C48H76N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1S50W1WU8T, chemically known as 4,4-sulfonylbis-(cyclopentanetridecananilide). but more generally known as chaulmosulfone, which bears US NIH Compound Identifier 193966. European Medicines Agency schedules Chaulmosulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07462MIG.

The term CHAULMOSULFONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). CHAULMOSULFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(C1CC(CC1)CCCCCCCCCCCCC(=O)NC1CCCCC1)C1CC(CC1)CCCCCCCCCCCCC(=O)NC1CCCCC1.

UNSPSC 51287003 Chaulmosulfone is a Commodity code that captures state and local procurement of specialized pharmaceutical compounds and related health-supply products. Recent state and local solicitations under this code show activity centered on public health emergency preparedness and community health initiatives, including purchases of naloxone for overdose response and safe drug deactivation systems, as well as piggyback access to broader pharmaceutical warehouse agreements for antibiotics and other clinical supplies. Issuing bodies include state health departments and county health authorities; the Illinois Department of Public Health and Seminole County, Florida both appear in recent records. The work reflects a mix of direct pharmaceutical procurement through cooperative purchasing consortiums (such as MMCAP) and standalone county-level competitive bids for community health supplies, with contracts typically structured as annual or multi-year awards with renewal options and quarterly or on-demand delivery terms.

Recent activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through MMCAP Infuse to Chartwell Rx LLC (Solicitation Number 26482DPHPREPDB53392, posted August 28, 2026) for pharmaceutical warehouse supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process with a 12-month initial term and renewal options through year 3. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, on a fixed-fee basis with a two-year initial term and one-year renewal option; the procurement carried potential FEMA funding and required E-Verify compliance and standard insurance coverage from bidders.